36 results
Thumbnail

D3.80 - Molecular allergy profiling of sensitization in adult patients with asthma in real practice

Thumbnail

D3.84 - Patterns of Sensitization to Artemisia and Ambrosia Pollen in Ukraine

Thumbnail

D3.90 - Outcomes of Beta-Lactam Allergy Evaluation in Patients with Suspected Hypersensitivity: One-Year Experience

Thumbnail

D3.78 - Association between lipocalin sensitization and clinical symptoms: Evidence for cross-reactivity

Thumbnail

D3.79 - Patterns of House Dust Mite Hypersensitivity in Eastern Ukraine

Thumbnail

D3.81 - Allergic Contact Dermatitis Induced by Transdermal Estradiol Hormone Replacement Therapy in a Postmenopausal Patient: A Case Report

Thumbnail

D3.82 - Conceptualization of a questionnaire for clinical diagnosis of house dust mite’s allergy

Thumbnail

D3.83 - A Case Report of Fenofibrate-Induced Fixed Drug Eruption Documented by Patch Testing and Oral Provocation

Thumbnail

D3.85 - Estrogen-Induced Drug Hypersensitivity Syndrome in a Patient with HHV-6 Reactivation

Thumbnail

D3.86 - ALEX versus ISAC. The same story or an improvement for allergologic molecular diagnostic?

Thumbnail

D3.87 - Evaluation of CD63 as a Marker of Basophil Degranulation in the Assessment of IgE-mediated Allergic Immune Responses

Thumbnail

D3.88 - Did the skin patch test sensitivity profiles change in young and middle-aged adult patients? Current data from a tertiary allergy clinic cohort

Thumbnail

D3.89 - Decoding a Triple Pediatric Food Allergy Phenotype Using Component-Resolved Diagnostics: Severe CMPA, Alpha-Gal, and PR-10–Mediated PFAS

Thumbnail

D3.91 - Molecular Profiling of Shrimp Allergy in Tunisia: The Role of Tropomyosin and Component-Resolved Diagnosis

Thumbnail

D3.92 - Precision Allergy Diagnostics in Tunisia: Integrating Molecular Allergology into the Management of Respiratory and Food Allergies

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial